J. Pers. Med. 2013, 3(3), 144-176; doi:10.3390/jpm3030144
Antisense Therapy in Neurology
1
Department of Medical Genetics, Faculty of Medicine and Dentistry, University of Alberta, 8812-112 St, Edmonton T6G 2H7, Canada
2
The Friends of Garrett Cumming Research and Muscular Dystrophy Canada HM Toupin Neurological Science Research Chair, 8812-112 St, Edmonton T6G 2H7, Canada
*
Author to whom correspondence should be addressed.
Received: 27 May 2013 / Revised: 26 July 2013 / Accepted: 29 July 2013 / Published: 2 August 2013
Abstract
Antisense therapy is an approach to fighting diseases using short DNA-like molecules called antisense oligonucleotides. Recently, antisense therapy has emerged as an exciting and promising strategy for the treatment of various neurodegenerative and neuromuscular disorders. Previous and ongoing pre-clinical and clinical trials have provided encouraging early results. Spinal muscular atrophy (SMA), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy (DMD), Fukuyama congenital muscular dystrophy (FCMD), dysferlinopathy (including limb-girdle muscular dystrophy 2B; LGMD2B, Miyoshi myopathy; MM, and distal myopathy with anterior tibial onset; DMAT), and myotonic dystrophy (DM) are all reported to be promising targets for antisense therapy. This paper focuses on the current progress of antisense therapies in neurology. View Full-TextKeywords:
Duchenne muscular dystrophy (DMD); Fukuyama congenital muscular dystrophy (FCMD); myotonic dystrophy (DM); spinal muscular atrophy (SMA); Huntington’s disease (HD); amyotrophic lateral sclerosis (ALS); limb-girdle muscular dystrophy 2B (LGMD2B); Miyoshi myopathy (MM); distal myopathy with anterior tibial onset (DMAT); antisense therapy
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).
Scifeed alert for new publications
Never miss any articles matching your research from any publisher- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Share & Cite This Article
MDPI and ACS Style
Lee, J.J.A.; Yokota, T. Antisense Therapy in Neurology. J. Pers. Med. 2013, 3, 144-176.
Related Articles
Article Metrics
Comments
[Return to top]
J. Pers. Med.
EISSN 2075-4426
Published by MDPI AG, Basel, Switzerland
RSS
E-Mail Table of Contents Alert